Expression and Role of the BDNF Receptor-TrkB in Rat Adrenal Gland under Acute Immobilization Stress.
We reported that plasma brain-derived neurotrophic factor (BDNF) was maximally elevated following a 60-min period of acute immobilization stress and that salivary glands were the main source of plasma BDNF under this stress condition. However, the expression pattern of the BDNF receptor, Tyrosine receptor kinase B (TrkB), under this condition has yet to be determined. We therefore investigated the effect of this stress on the expression level of TrkB in various rat organs using real-time PCR. No significant differences were found between controls and 60 min-stressed rats with respect to TrkB level in various organs. Only adrenal glands showed significantly increased TrkB mRNA levels after 60 min of stress. TrkB mRNA and protein were observed to localize in chromaffin cells. In addition, we investigated whether BDNF-TrkB interaction influences the release of stress hormones from PC12 cells, derived from chromaffin cells. Truncated receptor, TrkB-T1, was identified in PC12 cells using RT-PCR. Exposure of PC12 cells to BDNF induced the release of catecholamine. This BDNF-evoked release was totally blocked by administration of the K252a in which an inhibitor of Trk receptors. Thus, BDNF-TrkB interactions may modulate catecholamine release from adrenal chromaffin cells under acute stress conditions.
Department of Oral Pathology, Kanagawa Dental College Postgraduate School, Japan.
Yusuke
Y
Kondo
Juri
J
Saruta
Masahiro
M
To
Naoto
N
Shiiki
Chikatoshi
C
Sato
Keiichi
K
Tsukinoki
J Dent Res. 2006 Sep;85(9):844-8
16931869
Brain Res. 2008 Feb 21;1195:43-9
18191115
Stress. 2010 Jan;13(1):53-60
19658028
J Immunol. 2009 Dec 15;183(12):7778-86
19923466
Clin Chem Lab Med. 1998 Nov;36(11):855-8
9877091
Biochem Soc Trans. 2006 Aug;34(Pt 4):607-11
16856873
Brain Res Mol Brain Res. 1997 Jun;46(1-2):274-80
9191102
Cell Tissue Res. 1999 May;296(2):271-9
10382271
Cell. 2003 Jan 24;112(2):257-69
12553913
Neurosci Lett. 1999 May 28;267(2):81-4
10400217
Trends Neurosci. 1995 Jul;18(7):321-6
7571013
J Neurobiol. 1994 Nov;25(11):1373-85
7852992
Endocrinology. 2010 Apr;151(4):1695-703
20181798
J Dent Res. 2007 Mar;86(3):260-4
17314259
J Neurobiol. 1994 Nov;25(11):1386-403
7852993
J Biol Chem. 2008 Feb 8;283(6):3385-3391
18045880
Cells Tissues Organs. 2005;180(4):237-44
16330879
Proc Natl Acad Sci U S A. 1986 Aug;83(16):6184-7
3090553
J Neurochem. 2008 Jun;105(5):1939-47
18266935
J Biochem. 2002 Jun;131(6):887-94
12038986
Psychiatry Res. 2002 Mar 15;109(2):143-8
11927139
Histol Histopathol. 2010 Oct;25(10):1317-30
20712016
Peptides. 2007 Sep;28(9):1856-70
17512639
Brain Res Mol Brain Res. 1994 Dec;27(2):347-54
7898323
Neuropharmacology. 1998 Dec;37(12):1553-61
9886678
J Physiol Paris. 1996;90(3-4):157-64
9116659
Brain Res. 2006 Aug 30;1107(1):52-7
16854394
J Neurosci. 1998 Sep 15;18(18):7272-84
9736648
Toxicol In Vitro. 2010 Sep;24(6):1681-8
20570720
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):791-8
12556415
J Biol Chem. 1996 Aug 30;271(35):21100-7
8702878
J Biol Chem. 1996 Mar 8;271(10):5623-7
8621424
Neuroendocrinology. 2001 Sep;74(3):148-59
11528216
Acta Histochem Cytochem. 2007 Jul 3;40(3):93-9
17653301
J Neurochem. 1995 Apr;64(4):1780-9
7891106
Brain Res. 1996 Feb 12;709(1):122-301
8869564
Acta Histochem Cytochem. 2006 Jul 1;39(3):69-77
17327926
Physiol Behav. 1992 Feb;51(2):337-43
1557444
Annu Rev Neurosci. 1996;19:289-317
8833445
Neuron. 1989 Jun;2(6):1525-34
2697237
Nature. 1996 Jun 20;381(6584):706-9
8649517
Nature. 2003 Nov 6;426(6962):74-8
14603320